Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease

J Interv Cardiol. 2010 Oct;23(5):460-6. doi: 10.1111/j.1540-8183.2010.00585.x. Epub 2010 Aug 27.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acetylcysteine / therapeutic use
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Bicarbonates / administration & dosage*
  • Bicarbonates / therapeutic use
  • Buffers
  • Confidence Intervals
  • Contrast Media / adverse effects*
  • Cross-Over Studies
  • Female
  • Free Radical Scavengers / therapeutic use
  • Humans
  • Infusions, Intravenous
  • Kidney Failure, Chronic / chemically induced
  • Kidney Failure, Chronic / drug therapy
  • Kidney Failure, Chronic / prevention & control*
  • Length of Stay
  • Male

Substances

  • Bicarbonates
  • Buffers
  • Contrast Media
  • Free Radical Scavengers
  • Acetylcysteine